Injectable Drug Delivery Devices Market Size By Application, Industry Analysis Report, Regional Outlook (Europe, North America, Asia Pacific, Middle East & Africa, And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2030 (Recession Impact Analysis)
ID : MRU_
51060 | Date :
Jan, 2023 | Pages :
182 | Region : Global |
Publisher : RI
Injectable drug delivery devices are the devices used to administer drugs into the circulatory system. It is the most effective and common route for the administration of most therapeutic agents to ensure a quick response. Injectable drugs are used when patient is unconscious and require quick effect. These devices are majorly used during treatment of diseases like cancer and diabetes.
Increasing cancer population is the major factor for the growth of the market. Global injectable drug delivery devices market is driven by rising prevalence of chronic diseases, increasing occurrence of needle-stick injuries, increasing use of biologics. Technological advancements, improving patient compliance, beneficial reimbursement policies, increasing healthcare awareness and increasing geriatric population has also contributed to the growth of the market. Whereas, risk of blood-borne infections, safety concerns regarding the use of injectable, introduction of the alternative drug delivery devices would restrain the growth of the market.
The Global Injectable Drug Delivery Devices Market had reached xxx million USD with a CAGR xx from 2018-2022. Later on, it will go to xxx million USD in 2023 with a CAGR xx % from 2023-2030.
In the global Injectable Drug Delivery Devices Market, This report focuses particularly in North America, South America, Europe and Asia-Pacific, and Middle East and Africa. This report classifies the Market on the basis of application, type, regions, and manufactures.
In Market segmentation by manufacturers, the report covers the following companies-
Dickinson and Company
Baxter International
Schott
Eli Lilly
Pfizer
Gerresheimer
Terumo Corporation
Antares Pharma
Novo Nordik
Sanofi
Unilife Corporation
Zogenix
Hospira
Presage Bioscience
MicroCHIPS
Pearl Therapeutics
Genentech
Bend Research
In Market segmentation by geographical regions, the report has analysed the following regions-
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In Market segmentation by types :
Devices
Formulation
In Market segmentation by applications :
Immune Disorder
Cancer
Diabetes
Other
The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the Injectable Drug Delivery Devices Market for the forecast period 2023-2030?
• What are the driving forces in the Injectable Drug Delivery Devices Market for the forecast period 2023-2030?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the Injectable Drug Delivery Devices industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players? Any special requirements about this report, please let us know and we can provide custom report.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Injectable Drug Delivery Devices Market Size Growth Rate by Type (2020-2030)
1.3.2 Devices
1.3.3 Formulation
1.4 Market Segment by Application
1.4.1 Global Injectable Drug Delivery Devices Market Share by Application (2020-2030)
1.4.2 Immune Disorder
1.4.3 Cancer
1.4.4 Diabetes
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Injectable Drug Delivery Devices Production Value 2015-2030
2.1.2 Global Injectable Drug Delivery Devices Production 2015-2030
2.1.3 Global Injectable Drug Delivery Devices Capacity 2015-2030
2.1.4 Global Injectable Drug Delivery Devices Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2020-2030
2.2.1 Global Injectable Drug Delivery Devices Market Size CAGR of Key Regions
2.2.2 Global Injectable Drug Delivery Devices Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Injectable Drug Delivery Devices Capacity by Manufacturers
3.1.2 Global Injectable Drug Delivery Devices Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Injectable Drug Delivery Devices Revenue by Manufacturers (2018-2022)
3.2.2 Injectable Drug Delivery Devices Revenue Share by Manufacturers (2018-2022)
3.2.3 Global Injectable Drug Delivery Devices Market Concentration Ratio (CR5 and HHI)
3.3 Injectable Drug Delivery Devices Price by Manufacturers
3.4 Key Manufacturers Injectable Drug Delivery Devices Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Injectable Drug Delivery Devices Market
3.6 Key Manufacturers Injectable Drug Delivery Devices Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Devices Production and Production Value (2018-2022)
4.1.2 Formulation Production and Production Value (2018-2022)
4.2 Global Injectable Drug Delivery Devices Production Market Share by Type
4.3 Global Injectable Drug Delivery Devices Production Value Market Share by Type
4.4 Injectable Drug Delivery Devices Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Injectable Drug Delivery Devices Consumption by Application
6 Production by Regions
6.1 Global Injectable Drug Delivery Devices Production (History Data) by Regions 2015-2020
6.2 Global Injectable Drug Delivery Devices Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Injectable Drug Delivery Devices Production Growth Rate 2015-2020
6.3.2 United States Injectable Drug Delivery Devices Production Value Growth Rate 2015-2020
6.3.3 Key Players in United States
6.3.4 United States Injectable Drug Delivery Devices Import & Export
6.4 European Union
6.4.1 European Union Injectable Drug Delivery Devices Production Growth Rate 2015-2020
6.4.2 European Union Injectable Drug Delivery Devices Production Value Growth Rate 2015-2020
6.4.3 Key Players in European Union
6.4.4 European Union Injectable Drug Delivery Devices Import & Export
6.5 China
6.5.1 China Injectable Drug Delivery Devices Production Growth Rate 2015-2020
6.5.2 China Injectable Drug Delivery Devices Production Value Growth Rate 2015-2020
6.5.3 Key Players in China
6.5.4 China Injectable Drug Delivery Devices Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Injectable Drug Delivery Devices Consumption by Regions
7.1 Global Injectable Drug Delivery Devices Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Injectable Drug Delivery Devices Consumption by Type
7.2.2 United States Injectable Drug Delivery Devices Consumption by Application
7.3 European Union
7.3.1 European Union Injectable Drug Delivery Devices Consumption by Type
7.3.2 European Union Injectable Drug Delivery Devices Consumption by Application
7.4 China
7.4.1 China Injectable Drug Delivery Devices Consumption by Type
7.4.2 China Injectable Drug Delivery Devices Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Injectable Drug Delivery Devices Consumption by Type
7.5.2 Rest of World Injectable Drug Delivery Devices Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Dickinson and Company
8.1.1 Dickinson and Company Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Injectable Drug Delivery Devices
8.1.4 Injectable Drug Delivery Devices Product Introduction
8.1.5 Dickinson and Company Recent Development
8.2 Baxter International
8.2.1 Baxter International Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Injectable Drug Delivery Devices
8.2.4 Injectable Drug Delivery Devices Product Introduction
8.2.5 Baxter International Recent Development
8.3 Schott
8.3.1 Schott Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Injectable Drug Delivery Devices
8.3.4 Injectable Drug Delivery Devices Product Introduction
8.3.5 Schott Recent Development
8.4 Eli Lilly
8.4.1 Eli Lilly Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Injectable Drug Delivery Devices
8.4.4 Injectable Drug Delivery Devices Product Introduction
8.4.5 Eli Lilly Recent Development
8.5 Pfizer
8.5.1 Pfizer Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Injectable Drug Delivery Devices
8.5.4 Injectable Drug Delivery Devices Product Introduction
8.5.5 Pfizer Recent Development
8.6 Gerresheimer
8.6.1 Gerresheimer Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Injectable Drug Delivery Devices
8.6.4 Injectable Drug Delivery Devices Product Introduction
8.6.5 Gerresheimer Recent Development
8.7 Terumo Corporation
8.7.1 Terumo Corporation Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Injectable Drug Delivery Devices
8.7.4 Injectable Drug Delivery Devices Product Introduction
8.7.5 Terumo Corporation Recent Development
8.8 Antares Pharma
8.8.1 Antares Pharma Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Injectable Drug Delivery Devices
8.8.4 Injectable Drug Delivery Devices Product Introduction
8.8.5 Antares Pharma Recent Development
8.9 Novo Nordik
8.9.1 Novo Nordik Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Injectable Drug Delivery Devices
8.9.4 Injectable Drug Delivery Devices Product Introduction
8.9.5 Novo Nordik Recent Development
8.10 Sanofi
8.10.1 Sanofi Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Injectable Drug Delivery Devices
8.10.4 Injectable Drug Delivery Devices Product Introduction
8.10.5 Sanofi Recent Development
8.11 Unilife Corporation
8.12 Zogenix
8.13 Hospira
8.14 Presage Bioscience
8.15 MicroCHIPS
8.16 Pearl Therapeutics
8.17 Genentech
8.18 Bend Research
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Injectable Drug Delivery Devices Capacity, Production Forecast 2020-2030
9.1.2 Global Injectable Drug Delivery Devices Production Value Forecast 2020-2030
9.2 Market Forecast by Regions
9.2.1 Global Injectable Drug Delivery Devices Production and Value Forecast by Regions 2020-2030
9.2.2 Global Injectable Drug Delivery Devices Consumption Forecast by Regions 2020-2030
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Injectable Drug Delivery Devices Production Forecast by Type
9.7.2 Global Injectable Drug Delivery Devices Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Injectable Drug Delivery Devices Sales Channels
10.2.2 Injectable Drug Delivery Devices Distributors
10.3 Injectable Drug Delivery Devices Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porters Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
We are flexible and responsive startup research firm. We adapt as your research requires change, with cost-effectiveness and highly researched report that larger companies can't match.
Information Safety
Market Research Update ensure that we deliver best reports. We care about the confidential and personal information quality, safety, of reports. We use Authorize secure payment process.
We Are Committed to Quality and Deadlines
We offer quality of reports within deadlines. We've worked hard to find the best ways to offer our customers results-oriented and process driven consulting services.
Our Remarkable Track Record
We concentrate on developing lasting and strong client relationship. At present, we hold numerous preferred relationships with industry leading firms that have relied on us constantly for their research requirements.
Best Service Assured
Buy reports from our executives that best suits your need and helps you stay ahead of the competition.
Customized Research Reports
Our research services are custom-made especially to you and your firm in order to discover practical growth recommendations and strategies. We don't stick to a one size fits all strategy. We appreciate that your business has particular research necessities.
Service Assurance
At Market Research Update, we are dedicated to offer the best probable recommendations and service to all our clients. You will be able to speak to experienced analyst who will be aware of your research requirements precisely.